Treatment of an ulcerated hemangioma with recombinant platelet-derived growth factor

Arch Dermatol. 2002 Mar;138(3):314-6. doi: 10.1001/archderm.138.3.314.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Administration, Topical
  • Anti-Infective Agents / administration & dosage
  • Anti-Infective Agents / therapeutic use
  • Becaplermin
  • Drug Therapy, Combination
  • Female
  • Gels
  • Glucocorticoids / therapeutic use
  • Hemangioma / complications*
  • Hemangioma / drug therapy*
  • Hemangioma / pathology
  • Humans
  • Infant
  • Metronidazole / administration & dosage
  • Metronidazole / therapeutic use
  • Platelet-Derived Growth Factor / administration & dosage
  • Platelet-Derived Growth Factor / therapeutic use*
  • Prednisolone / therapeutic use
  • Proto-Oncogene Proteins c-sis
  • Ulcer / etiology*
  • Ulcer / pathology

Substances

  • Anti-Infective Agents
  • Gels
  • Glucocorticoids
  • Platelet-Derived Growth Factor
  • Proto-Oncogene Proteins c-sis
  • Metronidazole
  • Becaplermin
  • Prednisolone